Introduction: Immunoadsorption (IA) of isohemagglutinins is an often-crucial procedure in preparation of major ABO blood group-incompatible living donor kidney transplantation (ABOi LDKT). Standard citrate-based anticoagulation during the procedure has potential disadvantages for distinct patient groups. In this study, we report our experience with an alternative anticoagulation scheme using heparin during IA for selected patients.
View Article and Find Full Text PDFJ Allergy Clin Immunol Pract
November 2022
Future perspectives in Myelodysplastic Syndrome In the next years the role of molecular genetics will increase in diagnosis, prognosis and therapy of MDS. In the treatment of low risk MDS anemia remains the biggest challgenge. In the treatment of high risk MDS new promising drugs are entering the field and open the possibility of combination therapies.
View Article and Find Full Text PDFLangerhans cell histiocytosis (LCH) commonly co-occurs with additional myeloid malignancies. The introduction of targeted therapies, blocking "driver" mutations (e.g.
View Article and Find Full Text PDF